1. Home
  2. HLIT vs AVXL Comparison

HLIT vs AVXL Comparison

Compare HLIT & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLIT
  • AVXL
  • Stock Information
  • Founded
  • HLIT 1988
  • AVXL 2004
  • Country
  • HLIT United States
  • AVXL United States
  • Employees
  • HLIT N/A
  • AVXL N/A
  • Industry
  • HLIT Radio And Television Broadcasting And Communications Equipment
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HLIT Technology
  • AVXL Health Care
  • Exchange
  • HLIT Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • HLIT 1.0B
  • AVXL 956.7M
  • IPO Year
  • HLIT 1995
  • AVXL N/A
  • Fundamental
  • Price
  • HLIT $9.91
  • AVXL $9.37
  • Analyst Decision
  • HLIT Buy
  • AVXL Strong Buy
  • Analyst Count
  • HLIT 6
  • AVXL 2
  • Target Price
  • HLIT $11.50
  • AVXL $44.00
  • AVG Volume (30 Days)
  • HLIT 1.0M
  • AVXL 964.7K
  • Earning Date
  • HLIT 10-27-2025
  • AVXL 08-12-2025
  • Dividend Yield
  • HLIT N/A
  • AVXL N/A
  • EPS Growth
  • HLIT 16.91
  • AVXL N/A
  • EPS
  • HLIT 0.58
  • AVXL N/A
  • Revenue
  • HLIT $689,084,000.00
  • AVXL N/A
  • Revenue This Year
  • HLIT N/A
  • AVXL N/A
  • Revenue Next Year
  • HLIT $25.21
  • AVXL N/A
  • P/E Ratio
  • HLIT $17.17
  • AVXL N/A
  • Revenue Growth
  • HLIT 24.14
  • AVXL N/A
  • 52 Week Low
  • HLIT $7.80
  • AVXL $5.03
  • 52 Week High
  • HLIT $15.46
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • HLIT 60.04
  • AVXL 45.30
  • Support Level
  • HLIT $9.78
  • AVXL $8.82
  • Resistance Level
  • HLIT $10.19
  • AVXL $10.40
  • Average True Range (ATR)
  • HLIT 0.26
  • AVXL 0.53
  • MACD
  • HLIT 0.04
  • AVXL 0.03
  • Stochastic Oscillator
  • HLIT 73.58
  • AVXL 34.81

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: